Real-World Experience with AGA Guidelines in the Management of Crohn’s Disease following Ileocolonic Resection: A Retrospective Cohort Study

Table 2

Logistic regression analysis of postoperative endoscopic recurrence of CD.

	Univariate			Multivariate
	HR	95% CI		HR	95% CI
Gender	0.54	0.22-0.34	0.21
Age at diagnosis (Y)	0.83	0.23-2.96	0.89
Disease duration (<48 M)	0.74	0.36-1.56	0.44
Age at surgery (<29 Y)	1.54	0.74-3.21	0.25
Disease phenotype (Montreal classification)
B1	Reference
B2	0.36	0.14-0.92	0.03	0.73	0.26-1.38	0.28
B3	0.51	0.20-1.31	0.16
Perianal disease	0.85	0.39-1.82	0.67
Prior surgery related to CD	0.65	0.19-2.16	0.48
Active smokers	3.43	1.48-7.91	0.004	3.75	1.36-10.33	0.01
Preoperative medications
5-ASA	Reference
Azathioprine	0.70	0.33-1.52	0.37
Steroid	1.26	0.59-2.70	0.55
Infliximab	0.63	0.24-1.56	0.31
Immunomodulator and IFX	1.61	0.71-3.63	0.25
Appendix resection history	0.50	0.15-1.67	0.22
Postoperative complication	1.3	0.31-5.65	0.70
Adherence to AGA guideline	0.21	0.09-0.47	0.001	0.36	0.15-0.86	0.02